… overexpression of human epidermal growth factor receptor 2 (… insulin-like growth factor-1
receptor, other epidermal growth factor … Specifically, the epidermal growth factor receptor/HER2 …

… epidermal growth factor-like domain, MUC4 prevents it from binding to herceptin and may
increase phosphorylation of HER2, potentially altering signals sent from the HER2 receptor. …

… the human epidermal growth factor receptor HER) … epidermal growth factor receptor EGFR)
family, a group of EGFR tyrosine kinases3 that play an important role in controlling cell growth…

… DS-8201a is a human epidermal growth factor receptor 2 (HER2)-targeting antibody–drug …
The introduction of trastuzumab emtansine (T-DM1), a human epidermal growth factor …

… epidermal growth factor receptor 2 (HER2)–positive early breast cancer. We report the phase
III IMpassion050 primary analysis of neoadjuvant atezolizumab, PH, and chemotherapy in …

… of murine anti-human epidermal growth factor receptor antibody 528 (m528Fv). Grafting of
the CDRs of m528Fv onto a selected framework region of human antibodies, referred to as …

PURPOSE To investigate efficacy and safety of trastuzumab deruxtecan (T-DXd) in human
epidermal growth factor receptor 2 (HER2)–low gastric or gastroesophageal junction (GEJ) …

The anti-human epidermal growth factor receptor (EGF-R) humanized antibody h-R3 (IgG 1 ),
which binds to an extracellular domain of EGF-R, was used to evaluate the biodistribution …

PURPOSE The achievement of pathologic complete response (pCR) is strongly prognostic
for event-free survival (EFS) and overall survival (OS) in patients with early breast cancer (…

… Epidermal growth factor (EGF) stimulates the growth of many tissues and inhibits
stimulated … We used polyclonal anti-human EGF sera in the peroxidase-antiperoxidase …